Intrathecal Pump Refills at Home
Feasibility, Safety and Effectiveness of Intrathecal Pump Refills at Home: a Pilot Study.
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this pilot study is to evaluate the feasibility, safety and effectiveness of intrathecal pump refill procedures at home. It is our hypothesis that a refill at home will be safe, effectiveness and feasible, as is demonstrated in The Netherlands, and preferred by patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2021
CompletedStudy Start
First participant enrolled
August 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2021
CompletedFirst Posted
Study publicly available on registry
August 23, 2021
CompletedAugust 24, 2021
August 1, 2021
2 days
August 2, 2021
August 23, 2021
Conditions
Outcome Measures
Primary Outcomes (4)
Patient satisfaction
A seven-point Likert scale asking the patient to rate the overall level of satisfaction with the refill at home will be used.
Once, at the moment of the study visit, immediately after the pump refill
Successful pump refill
A binary variable to indicate success or failure of this intervention, reported by the physician.
Once, at the moment of the study visit, immediately after the pump refill
Patient safety
A seven-point Likert scale asking the patient to rate the overall level of safety with the refill at home will be used.
Once, at the moment of the study visit, immediately after the pump refill
Physician safety
A seven-point Likert scale asking the physician to rate the overall level of safety with the refill at home will be used.
Once, at the moment of the study visit, immediately after the pump refill
Secondary Outcomes (11)
Environmental safety
Once, at the moment of the study visit, immediately after the pump refill
Clean, sterile procedure
Once, at the moment of the study visit, immediately after the pump refill
An objective confirmation of correct injection in the pump by ultrasound.
Once, at the moment of the study visit, immediately after the pump refill
Adverse events
Once, at the moment of the study visit, immediately after the pump refill
Patient feasibility
Once, at the moment of the study visit, immediately after the pump refill
- +6 more secondary outcomes
Study Arms (1)
Refill at home
EXPERIMENTALPatients will have one pump refill at home instead of at the hospital.
Interventions
Eligibility Criteria
You may qualify if:
- Patient receives intrathecal drug therapy
- Patient is at least 18 years old
- Native French-or Dutch speaking persons.
You may not qualify if:
- Patients \< 18 years old.
- No native Dutch or French speaking persons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Moens Maartenlead
Study Sites (1)
Universitair Ziekenhuis Brussel
Jette, 1090, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
August 2, 2021
First Posted
August 23, 2021
Study Start
August 9, 2021
Primary Completion
August 11, 2021
Study Completion
August 11, 2021
Last Updated
August 24, 2021
Record last verified: 2021-08